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1. Introduction 
Although the mechanism of antibody-induced re- 
ceptor capping in lymphocytes is still a debated issue 
[ 11, it seems almost certain that actin microfiaments 
play some role in this process. Cytochalasin B (a micro- 
filament disrupting drug) inhibits cap formation and 
disperses already formed caps [2]. Immunofluores- 
cence studies have shown actin to accumulate beneath 
the cap [3,4] and, finally, biochemical analysis has 
shown both Hz-antigens and surface immunoglobulin 
to be associated with actin when patched or capped 
[5,61. 
Yet, the source of this cap-associated actin is not 
known. Conveivably, it could have formed by rearrange- 
ment of membrane-associated network-actin, by asso- 
ciation of the cap with existing cytoplasmic micro- 
filaments or by de novo assembly. This latter possibil- 
ity has become an attractive mechanism for a variety 
of cell functions. Recent reports indicate that non- 
muscle cells maintain relatively large pools of G-actin 
[7,8], which can be activated (presumably polymerized) 
upon request, i.e., upon receiving an appropriate stim- 
ulus [9,10]. Here we show that such an activation 
takes place when Thy-l antigens cap on the surface of 
mouse thymocytes. 
2. Materials and methods 
Ethidium bromide was obtained from British Drug 
House Ltd. DNase I, Sigma electrophoretically-pure, 
was used without further purification. Double-stranded 
DNA was Sigma-type 1, from calf thymus. Pure rabbit 
skeletal muscle G-actin was a gift from Drs A. Oplatka 
and J. Borejdo. All other reagents used were obtained 
from Sigma. 
Elsevier/North-Holland Biomedical Press 
2.1. Antisera 
Anti-Thy-l.2 was an AKR/J anti-C3H/eb serum 
prepared as in [ 111. Its titer was 1:256. FITC-rabbit 
antimouse IgG (FITC-RAM-IgG) was purchased from 
Miles Yeda. 
2.2. Determination of actin state and total actin 
Actin was determined by its inhibition of the en- 
zymatic activity of DNase I on double-stranded DNA. 
The procedure used was similar, in principle, to that 
in [ 121. However, it was rendered more sensitive by 
determining the DNA digestion through the fall in the 
fluorescence of a DNA-ethidium complex [ 131. The 
DNase I assay system contained: double-stranded DNA, 
6 X 10e2 mg; ethidium bromide, 3 X 10v9 mol; Tris- 
HCl (pH 8.0) 7.5 X 10e6 mol; CaC12, 0.6 X 10” mol; 
MgC12, 6 X 10m6 mol; in a total volume of 3.0 ml. 
Upon addition of DNase I, an initial short lag period 
was observed, followed by a linear fall in the fluores- 
cence (excitation 520 nm, emission 602 nm). This 
linear decrease was proportional to enzyme concentra- 
tion over 0.05-0.2 pg. Addition of muscle G-actin to 
the DNase I resulted in an immediate inhibition of its 
enzymatic activity, 1 .l mol G-actin inhibiting 1 .O 
mol DNase I. This inhibition was unaltered when per- 
formed in the presence of 1% Triton X-100. 
Cell samples (IO7 cells) were taken as required and 
mixed with an equal volume of Tris-saline (pH 7.4) 
containing 2% Triton X-l 00 and 0.2 yg DNase I. From 
this mixture samples were taken at 1 min and 180 
min for assay of DNase I activity. Inhibition after 1 
min is referred to as the fraction of the cellular actin 
in a ‘G-like state. The value obtained after 3 h was 
taken as that of total DNase I-available actin. In the 
absence of sodium azide this value coincides with im- 
mediate inhibition of cell lysates pretreated with 1.5 M 
guanidme-HCl as in [ 121. Inhibition was calculated 
from an equivalent sample of DNase I incubated under 
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similar conditions in the absence of cells. It was con- 
verted to actin concentrations via a calibration curve 
of pure muscle actin with DNase I. Protein concentra- 
tions in the cells were determined as in [ 141, using 
bovine serum albumin as a standard. 
3. Results 
Total DNase I-available actin in mouse thymocytes 
was found to give a value of 4.6% of the total cellular 
protein (table 1). This value is slightly lower than re- 
ported values of other non-muscle cells [ 151. In un- 
treated cells the V-like actin fraction represented 73% 
of the total actin. Upon incubation with anti-Thy-l .2 
alone, the total actin available for DNase I inhibition 
remained essentially the same, while the ‘G’-like actin 
consistently increased slightly. This increase was not 
significant due to the variability of the observed values. 
Upon addition of the second antibody (FITC-RAM- 
IgC), capping ensued upon incubation for 30 min at 
3 7°C. Assay of these fully-capped cells showed a 
highly significant (Jo < 0.001) decrease in the fraction 
of the actin leading to immediate DNase I inhibition 
(‘G’-like actin). Some 40% of the ‘G’-actin was now 
found to become incapable of rapid inhibition of the 
DNase I. 
The time-course of the ‘G’-actin mobilization was 
next studied (fig.1). Cells were preincubated with 
anti-Thy-l .2 for 10 min, and then FITC-RAM-IgG 
was added and the cells were assayed at different times 
for the fraction of ‘G’-like actin. It can be seen that 
incubation with FITC-RAM-IgG without anty-Thy- 
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Fig.1. Fraction of thymocyte actin capable of immediate 
DNase I inhibition during capping of Thy-l .2. Full circles 
represent capping cells, which have been pretreated with 
anti-Thy-1.2. (o) Control cells, not pretreated. To both con- 
trols and capping cells FITC-RAM-IgC has been added at 
time = 0. The first two points represent measurements taken 
just before addition of the second antibody after 10 min pre- 
incubation at 37°C. 
1.2 results in constant values of ‘G’-actin (-74% of 
the total). However, incubation with anti-Thy-l .2 
alone results again in a slight increase in the V-like 
actin. Upon addition of FITC-RAM-IgG, initiation 
of capping leads to a decrease in the fraction of ‘G‘- 
Table 1 
Distribution of ‘G-like actin in capped cells 
Additions to cells ‘(Y-like actin ‘T’ (total) actin C/T x 100 n 
(fig/100 c(g protein) (% cell protein) 
a. None 3.2 i 0.7 4.6 ? 1.3 73.2 * 15 6 
b. FITC-RAM-IgG 2.8 i- 0.8 3.5 + 0.8 , -.4 t 2.6 10 
c. Anti-Thy-l.2 4.2 i 1.9 5.0 * 2.1 82.3 ? 2.6 2 
d. Anti-Thy-l .2 and 
FITC-RAM-IgG 2.1 + 0.4 4.8 + 1.5 46.3 * 7.0 4 
C57BL/6J thymocytes were washed twice in isotonic Tris (pH 7.4) suspended to 
2 X 1 O7 cells/ml, mixed 1: 1 (v/v) with anti-Thy-l .2 (diluted 1: 10) and incubated 
30 min at 0°C. After 3 more washes, cells were resuspended to their original vol- 
ume and preincubated at 37°C for 10 min (c). Then, an equal volume of FITC- 
RAM-IgG (diluted 1:20) was added and cells incubated for another 30 min (d). 
Control cells (untreated with anti-Thy-l .2) were similarly incubated for 10 min 
at 37°C (a) and FITC-RAM-IgG added as before (b) 
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Table 2 
Effect of sodium azide on the state of thymocyte actin 
Additions to cells %‘-actin ‘T’-actin G/TX 100 
IO-‘M azide 1 min at 37°C 2.2 3.5 43.4 
1 O-‘M azide 30 min at 37’C 0.9 2.9 34 
lo-‘M azide + anti-Thy-l.2 (1 min) 2.6 f 0.1 4.2 t 0.6 63.6 t 4.3 
lO_‘M azide + anti-Thy-l .2 (30 min) 1.2 f 0.3 3.1 Z!. 0.4 37.4 * 6.2 
IO-*M azide + anti-Thy-l.2 + 
FITC-RAM (I min) 2.1 + 0.1 4.2 ?: 0.5 64.0 + 8.9 
1 O-‘M azide + anti-Thy-l.2 + 
FITC-RAM (30 min) 1.6 * 0.3 3.6 + 0.6 43.1 f 1.5 
like actin readily detected within 5 min and the values 
fall to a ~n~urn after some 10 min. Under the con- 
ditions used for capping, >90% of the cells were found 
to cap after 30 min. 
The next experiments were performed to determine 
whether the actin mobilization correlates with patch- 
ing of surface determinants orwith their actual cap- 
ping. The effect of the antibodies was studied in the 
presence of 10d2 M azide which is known to inhibit 
capping. The results are shown in table 2. The surpris- 
ing finding was observed that addition of azide alone 
results in a dramatic decrease in the “C’-actin. This 
decrease was already apparent after 1 min becoming 
much more pronounced after 30 min incubation 
with the azide (compare with (a), table 1). The addi- 
tion of the antibodies lightly counteracted the de- 
crease induced by the azide. However, the values at 
30 min were lower than those in the absence of sodium 
azide. It can be also observed in table 2 that in the 
presence of azide the values of the total actin capable 
of inhibiting DNase I were lower than those in its 
absence (table 1). 
Attempts to determine total actin by guanidine 
induced depolyme~zation [ 121 gave erratic results 
which require further study. 
4. Discussion 
These findings indicate that -5% of the total 
mouse thymocyte protein is capable of inhibiting 
DNase I activity. Of this, -75% is found in intact cells 
to be in a ‘G’-like form. It should be stressed that ‘G’- 
actin or ‘G-like actin is an operational definition, 
meaning the fraction capable of immediate DNase I
i~bition. Si~larly, the ‘F’-actin (defined as the dif- 
ference between the total actin leading to DNase I
inhibition and the ‘G’actin) can only tentatively be 
regarded as fdamentous actin. The V-like actin could 
be truly monomeric actin or some storage form [16, 
171, profiactin [ IS] or some actin gel [ 191. Pure ‘F’- 
actin does not immediately inhibit DNase I activity. 
It is however destabilized by DNase I and depolym- 
erizes to inhibit the DNase I with a half-life of -5 min 
[20]. Actomyosin in the absence of ATP is not depo- 
lymerized by DNase I and does not inhibit its activity. 
However, in the presence of ATP actomyosin behaves 
as ‘F’-actin [ZO]. 
With these qualifications in mind, it was found that 
binding of anti-Thy-l .2 and FITC-~-IgG causes 
a depletion of the ‘G-pool by -40% presumably lead- 
ing to actin poIyme~zation). Neither of the antibodies 
alone has a significant effect on ‘G’-actin levels. In 
this respect, the conditions for polymerization are the 
same as those for capping. The time-course of polym- 
erization (f&.1), however, seems to precede capping_ 
While it take some 30 min incubation with FITC- 
RAM-IgG to observe >90% capped cells, the polym- 
erization requires roughly 10 min to reach a plateau. 
It is a general, accepted working hypothesis that 
antibody or hgand-induced receptor capping follows 
a sequence, which includes: 
(i) ~gand-induced receptor ~cr~~regates or 
patches; 
(ii) Association of such clustered receptors with actin 
microfilaments; 
(iii) Active displacement of the clustered receptors 
towards the uropod, leading to the formation of 
a cap. 
This energy-dependent step involves actomyosin and 
leads to a redistribution, ot only of the clustered 
receptors but also of the actomyosin which is found 
mainly under the capped material (see discussion i  
1211). 
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The manner in which clustered receptors become 
associated with the actomyosin network is not clear. 
Some models postulate the direct binding of the clus- 
ters to preformed actin microfilaments. Alternatively 
the microfilaments are envisaged to be attached to a 
component X to which the clusters bind for their 
ulterior co-capping to the uropod [4]. Neither of the 
alternative models has received experimental support. 
A third possibility could be envisaged on the basis of 
the present data: cluster-formation might be a trigger 
to lead to a mobilization of precursor actin from some 
gel or storage form to that of microfilaments. This 
would mean that actin-microfnaments could actually 
form beneath a given cluster, might thus become at- 
tached to the receptors and be capable of selectively 
inducing their redistribution. 
This hypothesis does not entirely rule out a role 
for protein X. Conceivably, clustering of receptors 
forms a nucleation center for actin polymerization. 
A similar nucleating structure (the acromere) has been 
described in sperm [22]. Protein X could be an essen- 
tial component of this nucleation site rather than an 
anchor for preexisting filaments. 
As mentioned a definite understanding of the azide 
effect requires further investigation. However, it is 
apparent that it is a biphasic effect: a rapid depletion 
of ‘G’-actin (presumably by polymerization) followed 
by transformation of the filaments to a state of par- 
tial resistence to depolymerization by DNase I. Since 
a major consequence of azide incubation is a fall in 
intracellular ATP this second state may be akin to an 
actomyosin rigor complex. It is conceivable that 
myosin binding to actin also induces the observed 
polymerization. Alternatively, polymerization may be 
a secondary effect of ATP depletion via changes in 
the ionic environment. Thus, ATP depletion could 
lead to Ca*+ influx due to an inhibition of the Ca- 
ATPases of the cell. 
Whatever the precise mechanism of azide induced 
‘G’-actin depletion may be, it suggests an interesting 
explanation for inhibition of capping. Rather than 
preventing the pulling of clusters into caps by an 
energy-dependent actomyosin contraction, inhibition 
could act at an earlier stage: the azide induced deple- 
tion of the ‘G’-pool would no longer allow for direc- 
tional polymerization onto receptor clusters so that 
the process is inhibited at the stage of selective associa- 
tion of patches with filaments. 
References 
[I] Bray, D. (1978) Nature 273, 265-266. 
[2] de Petris, S. (1975) J. Cell. Biol. 65, 1233146. 
[3] Sundquist, K. G. and Ehrnst, A. (1976) Nature 264, 
226-231. 
[4] Bourgignon, L. Y. W. and Singer, S. J. (1977) Proc. 
Natl. Acad. Sci. USA 74,5031-5035. 
[5] Koch, G. L. E. and Smith, M. G. (1978) Nature 273, 
274-278. 
[6] Flanagan, J. and Koch, G. L. E. (1978) Nature 273, 
2788281. 
[7] Bray, D. and Thomas, C. (1976) J. Mol. Biol. 105, 
527-544. 
[8] Hinssen, H. (1972) Cytobiologie 5, 146. 
[9] Carlsson, L., Markey, F., Blikstad, I., Persson, T. and 
Lindberg, U. (1979) Proc. Natl. Acad. Sci. USA 76, 
6376-6380. 
[IO] Gitler, C., Pribluda, V., Laub, F. and Rotman, A. 
(1980) m: Platelets: Cellular response mechanisms and 
their biological significance (Rotman, A. et al. eds) 
pp. 193-198, Wiley, New York. 






Blikstad, I., Markey, F., Carlsson, L., Persson, T. and 
Lindberg, U. (1978) Cell 15,935-943. 
Le Pecq, J. B. Y. and Paoletti, C. (1964) Compt. Rend. 
Acad. Sci. 259, 1786. 
Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193, 265-275. 
Tilney, L. G. (1975) in: Molecules and Cell Movement 
(Inoub. S. and Stephens, R. E. eds) pp. 339-388, 
Raven Press, New York. 
Tilney, L. G. (1976) J. Cell. Biol 69, 73-89. 
Rohr, G. and Mannherz, H. G. (1978) Eur. J. Biochem. 
89, 151-157. 
Carlsson, L., NystrSm, L. E., Sundkrist, 1.. Markey, I:. 
and Lindberg, U. (1977) J. Mol. Biol. 115,465-483. 
Taylor, D. L. and Condeelis, J. (1979) bit. Rev. Cytol. 
56.577144. 
1201 Hitchcock, S. E., Carlsson. L. and Lindberg, U. (1976) 
Cell 7,531-542. 
1211 Schreiner,G. F. and Unanue, E. R. (1976) Adv. 
Immunol. 24,37- 159. 
[22] Tilney, L. G. (1978) J. Cell. Biol. 77,551-564. 
38 
